Understanding Treatment and Management of Myeloproliferative Neoplasms (MPNs) | New York, NY

A Town Meeting for MPN Patients and Their Loved Ones 

Sunday, May 15, 2016
New York, NY

 

An audience of MPN patients and their caregivers joined us at a recent town meeting along with The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center to hear the latest treatment and research news, inspiring stories of people living well with MPNs, tips for effective communication with a healthcare team and more.

We are also planning events in other cities. If you haven’t already, please sign up for email updates so we can alert you when important and inspiring videos become available and when upcoming town meetings are scheduled.

 

Patient Folder

 



The Goal of Essential Thrombocythemia (ET) Treatment

MPN expert, Dr. John Mascarenhas from Mount Sinai School of Medicine, explains the goal of various common treatments for essential thrombocythemia (ET).

Published:

Treating Polycythemia Vera (PV) With Phlebotomy

Dr. Mark Heaney from Columbia University Medical Center discusses phlebotomy, the cornerstone of polycythemia vera (PV) treatment, as well as cytoreductive therapies.

Published:

Assessing the Risk for Progression in MPNs

Dr. Mark Heaney, an expert on myeloproliferative neoplasms (MPNs), answers questions regarding the connection between ET and PV and their potential progression to MF.

Published:

Everyone's MPN Is Different: Finding the Best Treatment Plan for You

At a recent town meeting in New York City, MPN experts, Drs. Mark Heaney and John Mascarenhas, discuss why personalized care is important for each person living with an MPN (myeloproliferative neoplasm

Published:

Expert Update: The Status of JAK Inhibitors in Development

What is the developmental status of JAK inhibitors? Drs. Mark Heaney and John Mascarenhas update us on this extremely important question.

Published:

Expert Perspective: Advancing MPN Treatment Through Education and Clinical Trials

Dr. John Mascarenhas from Mount Sinai School of Medicine shares his expert opinion on current MPN laboratory and clinical research, and how this information can be optimized by both patients and providers.

Published:

Expert Perspective: Living Longer and Better With MPNs

MPN specialist Dr. Mark Heaney discusses his role at Columbia University Medical Center and his approach to patient care. He explains why MPNs are referred to as cancers and the advances being made in research in the field.

Published:

Understanding Treatment and Management of Myeloproliferative Neoplasms (MPNs) – Afternoon Session in New York, NY

This replay of the MPN town meeting from New York City in partnership with The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center features renowned experts discussing the latest research and treatment for MPNs.

Published:

Understanding Treatment and Management of Myeloproliferative Neoplasms (MPNs) – Morning Session in New York, NY

This replay of the MPN town meeting from New York City in partnership with The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center features renowned experts discussing the latest research and treatment for MPNs.

Published:



Guest Presenters

Associate Clinical Professor of Medicine

Columbia University Medical Center


Associate Professor of Medicine Myeloproliferative Disorders Program Tisch Cancer Institute, Division of Hematology/Oncology

Mount Sinai School of Medicine


Clinical Nurse

Columbia University Medical Center


Oncology Social Worker

Columbia University Medical Center


Patient Advocate


Hosts

Host, Patient Power Co-Founder, Two-Time Cancer Survivor and Patient Advocate


Online Host, Patient Power Co-Founder, Caregiver and Patient Advocate



This town meeting was sponsored by Incyte Corporation. It was produced by Patient Power in partnership with The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center. 










Page last updated on August 30, 2016
<